Therefore while p38 signaling may have dual roles in CLL, we have demonstrated here that it is involved in SOCS3 up-regulation and the cytotoxic mechanism of 17-DMAG treatment. The gene discussed is SOCS3; the disease is B-cell chronic lymphocytic leukemia.